Xtant Medical is a medical devices business based in the US. Xtant Medical shares (XTNT) are listed on the NYSE MKT and all prices are listed in US Dollars. Its last market close was $0.41 – a decrease of 3.56% over the previous week. Xtant Medical employs 207 staff and has a trailing 12-month revenue of around $110.9 million.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $0.41 |
|---|---|
| 52-week range | $0.43 - $1.45 |
| 50-day moving average | $0.58 |
| 200-day moving average | $0.77 |
| Wall St. target price | $2.25 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-0.01 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $0.41 from 2024-11-20
| 1 week (2024-11-15) | -4.65% |
|---|---|
| 1 month (2024-10-23) | -24.07% |
| 3 months (2024-08-22) | -34.92% |
| 6 months (2024-05-22) | -47.44% |
| 1 year (2023-11-22) | -66.94% |
|---|---|
| 2 years (2022-11-22) | -33.87% |
| 3 years (2021-11-22) | 0.8175 |
| 5 years (2019-11-22) | 1.82 |
| Revenue TTM | $110.9 million |
|---|---|
| Gross profit TTM | $32.1 million |
| Return on assets TTM | -10.58% |
| Return on equity TTM | -8.77% |
| Profit margin | -3% |
| Book value | $0.39 |
| Market Capitalization | $62.3 million |
TTM: trailing 12 months
We're not expecting Xtant Medical to pay a dividend over the next 12 months.
Xtant Medical's shares were split on a 1:12 basis on 13 February 2018 . So if you had owned 12 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Xtant Medical shares – just the quantity. However, indirectly, the new 1100% higher share price could have impacted the market appetite for Xtant Medical shares which in turn could have impacted Xtant Medical's share price.
Over the last 12 months, Xtant Medical's shares have ranged in value from as little as $0.425 up to $1.45. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while Xtant Medical's is 0.385. This would suggest that Xtant Medical's shares are less volatile than average (for this exchange).
Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons. It offers OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSelect DBM Putty to mold into any shape and compressed into bony voids; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, a growth factor enriched cellular bone matrix; and nanOss family of products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier. It also processes and distributes sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. In addition, it offers Certex spinal fixation, Spider cervical plating, Streamline OCT, CervAlign, Axle interspinous fusion, Xpress minimally invasive pedicle screw, Fortex pedicle screw, Axle-X interspinous fusion, Streamline MIS spinal fixation, Streamline TL spinal fixation systems, and Silex sacroiliac joint fusion systems. Further, it provides Calix for cervical and thoracolumbar applications, as well as Irix-C Cervical Integrated Fusion, Irix-A Lumbar Integrated Fusion, Fortilink, and Irix-A Lumbar integrated fusion systems; Coflex device for lumbar spinal stenosis; and CoFix implant for back and disc pain. The company is headquartered in Belgrade, Montana.
Robinhood Launches Presidential Election Event Contracts Ahead of the Nov 5 Presidential Election
Explore the best bonuses for opening a new brokerage account.
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
Compare pros, cons, research tools and reviews for these two trading platforms.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
What you need to know about investing in the leading indicator for the overall US stock market.
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
Top ways to invest $20K include stocks, retirement accounts, conservative investments, ETFs and more. See our full list here.
A deep dive into the highlights and limitations of Robinhood.